In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned committee meeting:
Times and Dates:
4 p.m.-7 p.m., March 5, 2007.
9 a.m.-5 p.m., March 6, 2007.
4 p.m.-7 p.m., March 7, 2007.
9 a.m.-5 p.m., March 8, 2007.
9 a.m.-5 p.m., March 9, 2007.
Place: Sheraton Midtown Atlanta Hotel Colony Square Atlanta, GA 30361.
Open: 4 p.m.-5 p.m., March 5, 2007.
Closed: 5 p.m.-7 p.m., March 5, 2007.
Closed: 9 a.m.-5 p.m., March 6, 2007.
Open: 4 p.m.-5 p.m., March 7, 2007.
Closed: 5 p.m.-7 p.m., March 7, 2007.
Closed: 9 a.m.-5 p.m., March 8, 2007.
Closed: 9 a.m.-5 p.m., March 9, 2007.
Purpose: This group is charged with providing advice and guidance to the Secretary, Department of Health and Human Services, and the Director, CDC, concerning the scientific and technical merit of grant and cooperative agreement applications received from academic institutions and other public and private profit and nonprofit organizations, including State and local government agencies, to conduct specific injury research that focuses on prevention and control.
Matters To Be Discussed: Agenda items include an overview of the injury program, discussion of the review process and panelists' responsibilities, and the review of and vote on applications. Beginning at 4 p.m., March 5, through 5 p.m., March 9, the Group will review individual research grant and cooperative agreement applications submitted in response to two Fiscal Year 2007 Requests for Applications related to the following individual research announcements: #07009, Dissertation Grant Awards for Doctoral Candidates for Violence-Related Injury Prevention Research in Minority Communities, and #07010, Research for Preventing Violence and Violence-Related Injury. This portion of the meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Section 10(d) of Public Law 92-463.
Agenda items are subject to change as priorities dictate.
For Further Information Contact: Gwendolyn H. Cattledge, Ph.D., M.S.E.H., Executive Secretary, NCIPC/IRG, CDC, 4770 Buford Highway, NE, M/S K02, Atlanta, Georgia 30341-3724, telephone 770/488-1240.
The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry.Start Signature
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. E7-2430 Filed 2-12-07; 8:45 am]
BILLING CODE 4163-18-P